Detalhe da pesquisa
1.
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing.
Cell
; 182(5): 1232-1251.e22, 2020 09 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32822576
2.
Rho/ROCK pathway inhibition by the CDK inhibitor p27(kip1) participates in the onset of macrophage 3D-mesenchymal migration.
J Cell Sci
; 127(Pt 18): 4009-23, 2014 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25015295
3.
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.
Nat Genet
; 56(1): 60-73, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38049664
4.
3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib.
Commun Biol
; 6(1): 509, 2023 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37169941
5.
Evolution of metastasis: new tools and insights.
Trends Cancer
; 8(2): 98-109, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34872888
6.
Stepwise evolution of therapy resistance in AML.
Cancer Cell
; 39(7): 904-906, 2021 07 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34171262
7.
Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer.
Clin Cancer Res
; 26(2): 439-449, 2020 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31548343
8.
Synthetic Essentiality of Metabolic Regulator PDHK1 in PTEN-Deficient Cells and Cancers.
Cell Rep
; 28(9): 2317-2330.e8, 2019 08 27.
Artigo
Inglês
| MEDLINE | ID: mdl-31461649
9.
The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy.
Cancer Immunol Res
; 6(11): 1337-1351, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30181209
10.
Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib.
Commun Biol
; 6(1): 608, 2023 Jun 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37280434
11.
Immune cell Toll-like receptor 4 mediates the development of obesity- and endotoxemia-associated adipose tissue fibrosis.
Cell Rep
; 7(4): 1116-29, 2014 May 22.
Artigo
Inglês
| MEDLINE | ID: mdl-24794440